Nasdaq
ABOS
Acumen Pharmaceuticals, Inc.
- Health Care
- Listed 2021
- 1 day
- +1.8%
- 1 month
- −11.3%
- 1 year
- +62.9%
$2.28 · Mkt cap $165M
At the 6 Aug 2026 close
Nasdaq
Acumen Pharmaceuticals, Inc.
$2.28 · Mkt cap $165M
At the 6 Aug 2026 close
Acumen Pharmaceuticals, Inc. trades under the ticker ABOS on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2021. Its market capitalisation is $165M. The last closing price was $2.28, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +62.9%, and −11.3% over the past month. Returns are price returns and exclude dividends.
This page exists because ABOS is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.